STIM
#3554
Neuronetics, Inc. - Common Stock
2.9 5 USD
0.00%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-0.34%
Monthly Change
+58.60%
6 month change
+128.68%
Year Change
-14.74%
Previous Close
2.9 6
Open
2.9 6
Low
2.9 4
High
2.9 9
Volume
82
Financials
- Market Capitalization 224.78 M
- Employee 658
- Founded 2003
- CEO N/A
- Website www.neurostar.com
- Headquarter Delaware, United States
- FIGI BBG000QX36J1
- Industry Diagnostics & Research
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-2.34
Price to sales ratio
0.65
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3333 |  BDSX Biodesix, Inc. - Common Stock | 28.25 USD | -0.81% | +16.88% | +33.00% | +125.82% | 298.07 M USD | ||
| 3467 |  LAB Standard BioTools Inc. - Common Stock | 0.65 USD | 0.00% | -1.52% | -16.67% | -50.38% | 255.18 M USD | ||
| 3679 |  XGN Exagen Inc. - Common Stock | 7.51 USD | -0.13% | -4.57% | +68.39% | -23.05% | 181.93 M USD | ||
| 3794 |  IMDX Insight Molecular Diagnostics Inc. - Common Stock | 4.29 USD | -0.23% | -2.50% | -6.54% | +70.98% | 140.39 M USD |
Frequently asked questions about Neuronetics, Inc. Common Stock
What is the Neuronetics, Inc. Common Stock stock price today?
The current price of Neuronetics, Inc. Common Stock (STIM) is 2.95. Over the past 24 hours, the stock has changed by -0.34%. Follow the STIM chart for real-time price dynamics.
What is the stock ticker of Neuronetics, Inc. Common Stock?
Neuronetics, Inc. Common Stock trades under the ticker STIM. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Neuronetics, Inc. Common Stock stock going up?
STIM has changed by -4.22% over the last week, +58.60% over the last month, and -14.74% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Neuronetics, Inc. Common Stock?
Neuronetics, Inc. Common Stock currently has a market capitalization of 224.78 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Neuronetics, Inc. Common Stock earnings last quarter?
Last quarter, Neuronetics, Inc. Common Stock reported earnings of -0.05 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Neuronetics, Inc. Common Stock revenue for the last quarter?
Neuronetics, Inc. Common Stock reported quarterly revenue of 39.47 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Neuronetics, Inc. Common Stock net income for the last quarter?
Neuronetics, Inc. Common Stock reported net income of -3.44 M for the last quarter. The previous quarter showed -10.79 M, which means net income changed by +68.13%.
How many employees does Neuronetics, Inc. Common Stock have?
As of the latest available data, Neuronetics, Inc. Common Stock has 658 employees. Workforce size can provide additional context about the company's scale and operations.
What is Neuronetics, Inc. Common Stock EBITDA?
Neuronetics, Inc. Common Stock EBITDA is -2.87 M, and its EBITDA margin is -7.28%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Neuronetics, Inc. Common Stock stock?
You can buy Neuronetics, Inc. Common Stock (STIM) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Neuronetics, Inc. Common Stock stock?
Investing in Neuronetics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the STIM chart and related analysis on metatrader.com as part of your research.